A detailed history of Summit Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Summit Wealth Partners, LLC holds 481 shares of LLY stock, worth $360,711. This represents 0.08% of its overall portfolio holdings.

Number of Shares
481
Previous 398 20.85%
Holding current value
$360,711
Previous $360 Million 18.28%
% of portfolio
0.08%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$772.14 - $960.02 $64,087 - $79,681
83 Added 20.85%
481 $426 Million
Q3 2023

Sep 11, 2024

BUY
$434.7 - $599.3 $173,010 - $238,521
398 New
398 $214 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Summit Wealth Partners, LLC Portfolio

Follow Summit Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Wealth Partners, LLC with notifications on news.